drug · antibody
patient view →bevacizumab biosimilar
pre_registrationupdated 2mo agoby Shanghai Henlius Biotech Inc🔗 ChEMBL
community read0 votes
Antibody drug with a maximum clinical stage of Approval (across all indications), with 20 approved and 146 investigational indications.
indications
indications
NSCLC
targets
Vascular endothelial growth factor A, long form
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that